Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

Vakiani E, Janakiraman M, Shen R, Sinha R, Zeng Z, Shia J, Cercek A, Kemeny N, D'Angelica M, Viale A, Heguy A, Paty P, Chan TA, Saltz LB, Weiser M, Solit DB.

J Clin Oncol. 2012 Aug 20;30(24):2956-62. doi: 10.1200/JCO.2011.38.2994. Epub 2012 Jun 4.

PMID:
22665543
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Baas JM, Krens LL, Guchelaar HJ, Morreau H, Gelderblom H.

Oncologist. 2011;16(9):1239-49. doi: 10.1634/theoncologist.2011-0024. Epub 2011 Jul 8. Review.

PMID:
21742964
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Concordant KRAS mutations in primary and metastatic colorectal cancer tissue specimens: a meta-analysis and systematic review.

Han CB, Li F, Ma JT, Zou HW.

Cancer Invest. 2012 Dec;30(10):741-7. doi: 10.3109/07357907.2012.732159. Epub 2012 Oct 17. Review.

PMID:
23075074
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk